By targeting YOD1, a deubiquitinase that stabilizes the E3 ubiquitin ligase ITCH, it indirectly suppresses large tumor suppressor kinase (LATS) and activates YAP/TAZ, enhancing liver growth and tumor progression [38]. This evidence concerns the gene YAP1 and neoplasm.